IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

SymBiosis Capital Partners, LLC

Q1 2026 Holdings

Filed 2026-05-12 | 6 holdings | $52.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Evommune, Inc.(EVMN)COM SHS30054Y107$29.4M1,280,77855.8%
Inventiva S.A.(IVA)ADS46124U107$13.1M2,354,00024.8%
Wave Life Sciences Ltd.(WVE)SHSY95308105$5.4M750,00010.3%
Rani Therapeutics Holdings, Inc.(RANI)COM CL A753018100$2.7M3,667,5855.1%
Clene Nanomedicine Inc.(CLNN)COM NEW185634201$2.1M431,0944.0%
Surrozen, Inc.(SRZNW)*W EXP 08/01/20386889P117$2.4K150,0000.0%